Department of Sociomedical Sciences, Columbia University Mailman School of Public Health. 722 West 168th Street, New York, NY, 10032 USA.
Department of Epidemiology, Columbia University Mailman School of Public Health. 722 West 168th Street, New York, NY, 10032 USA.
Drug Alcohol Depend. 2019 Nov 1;204:107506. doi: 10.1016/j.drugalcdep.2019.06.009. Epub 2019 Aug 26.
Research demonstrates an association between state-level medical marijuana laws (MMLs) and increased marijuana use (MU) and MU disorder (MUD) among adults, but has yet to explore this association among lesbian, gay and bisexual (LGB) individuals, including gender differences.
We pooled the 2015-2017 National Survey on Drug Use and Health data for adults (n = 126,463) and used gender-stratified adjusted multivariable logistic regression to model the odds of past-year MU, past-year medical MU, daily/near-daily MU, and MUD; we also tested the interaction between MML state residence and sexual identity.
Bisexual women had higher past-year MU (40% versus 10.3%; aOR = 2.9[2.4-3.4]), daily/near-daily MU (9.8% versus 1.5%; aOR = 4.6[3.3-6.2]), and medical MU ((5.5% versus 1.2%) aOR = 5.5[3.8-8.1]) than heterosexual women. Gay/lesbian women also had higher past-year MU (26.1% versus 10.3%; aOR = 2.8[2.2-3.7]), daily/near-daily MU (5.6% versus 1.5%; aOR = 2.9[1.8-4.6]), and medical MU (4.7% versus 1.2%; aOR = 3.0(1.4-6.6]) than heterosexual women. Bisexual women in MML states had higher past-year MU ((44.4% vs. 34.1%); aOR = 1.8[1.5-2.1]) and medical use (7.1% vs. 3.3% (aOR = 2.5[1.5-3.9]) than bisexual women in non-MML states. The odds of any past-year medical MU for bisexual versus heterosexual women was different in MML versus non-MML states (Exponentiated β = 0.53, p = 0.01). Gay men in MML states had higher past year MU (31.2% versus 25.7%; aOR = 1.6[1.1-2.5] and medical MU (6.4% vs 1.7%; aOR = 5.0[4.2-6.1]) than gay men in non-MML states.
Results suggest that MMLs may differentially impact MU for sexual minority individuals-particularly bisexual women. Findings demonstrate the need for states enacting MMLs to consider potential differential impacts on LGB populations.
研究表明，州级医用大麻法（MML）与成年人中大麻使用（MU）和大麻使用障碍（MUD）的增加之间存在关联，但尚未探讨 LGB 人群（包括性别差异）中的这种关联。
我们汇总了 2015-2017 年全国药物使用和健康调查数据（n=126463 名成年人），并使用性别分层调整后的多变量逻辑回归模型来模拟过去一年 MU、过去一年医用 MU、每日/近乎每日 MU 和 MUD 的几率；我们还测试了 MML 州居住与性身份之间的交互作用。
双性恋女性过去一年 MU 的发生率更高（40% 与 10.3%；aOR=2.9[2.4-3.4]），每日/近乎每日 MU 的发生率更高（9.8% 与 1.5%；aOR=4.6[3.3-6.2]），以及医用 MU（5.5% 与 1.2%；aOR=5.5[3.8-8.1]）比异性恋女性高。同性恋/女同性恋女性过去一年 MU 的发生率也更高（26.1% 与 10.3%；aOR=2.8[2.2-3.7]），每日/近乎每日 MU 的发生率更高（5.6% 与 1.5%；aOR=2.9[1.8-4.6]），以及医用 MU（4.7% 与 1.2%；aOR=3.0[1.4-6.6]）比异性恋女性高。在 MML 州的双性恋女性过去一年 MU 的发生率（44.4% 与 34.1%；aOR=1.8[1.5-2.1]）和医用 MU 的发生率（7.1% 与 3.3%（aOR=2.5[1.5-3.9]））都比非 MML 州的双性恋女性高。在 MML 州，双性恋女性与异性恋女性相比，任何过去一年医用 MU 的几率（Exponentiated β=0.53，p=0.01）都不同。在 MML 州的男同性恋者过去一年 MU 的发生率（31.2% 与 25.7%；aOR=1.6[1.1-2.5]）和医用 MU 的发生率（6.4% 与 1.7%；aOR=5.0[4.2-6.1]）都比非 MML 州的男同性恋者高。
结果表明，MML 可能会对性少数群体的 MU 产生不同的影响，特别是双性恋女性。研究结果表明，实施 MML 的各州需要考虑对 LGB 人群的潜在差异影响。
